These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17508963

  • 1. Asthma treatment: 'magic bullets which seek their own targets'.
    Tarantini F, Baiardini I, Passalacqua G, Braido F, Canonica GW.
    Allergy; 2007 Jun; 62(6):605-10. PubMed ID: 17508963
    [Abstract] [Full Text] [Related]

  • 2. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D.
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [Abstract] [Full Text] [Related]

  • 3. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 4. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G.
    Expert Opin Biol Ther; 2003 Apr 08; 3(2):371-6. PubMed ID: 12662149
    [Abstract] [Full Text] [Related]

  • 5. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep 08; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

  • 6. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.
    Ther Adv Respir Dis; 2008 Dec 08; 2(6):409-21. PubMed ID: 19124386
    [Abstract] [Full Text] [Related]

  • 7. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A, Sternon J.
    J Pharm Belg; 2006 Dec 08; 61(3):83-7. PubMed ID: 17058881
    [Abstract] [Full Text] [Related]

  • 8. Anti-IgE in severe persistent allergic asthma.
    Fox H.
    Respirology; 2007 Nov 08; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD, Turk F.
    Allergy; 2008 Jun 08; 63(6):670-84. PubMed ID: 18445184
    [Abstract] [Full Text] [Related]

  • 10. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P, Sauty A, Rochat T.
    Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R, Chung KF, Panahloo Z, Blogg M, Ayre G.
    Respir Med; 2008 Oct 10; 102(10):1371-8. PubMed ID: 18657960
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U, DUAL study group.
    Clin Exp Allergy; 2009 Feb 10; 39(2):271-9. PubMed ID: 19016798
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Omalizumab: overview of pharmacology and efficacy in asthma.
    Ledford DK.
    Expert Opin Biol Ther; 2009 Jul 10; 9(7):933-43. PubMed ID: 19527111
    [Abstract] [Full Text] [Related]

  • 19. Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis.
    Maykut RJ, Kianifard F, Geba GP.
    J Asthma; 2008 Apr 10; 45(3):173-81. PubMed ID: 18415822
    [Abstract] [Full Text] [Related]

  • 20. Reduction of the total IgE level by omalizumab in children and adolescents.
    Steiss JO, Strohner P, Zimmer KP, Lindemann H.
    J Asthma; 2008 Apr 10; 45(3):233-6. PubMed ID: 18415832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.